Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Massachusetts General Hospital/Harvard University, Boston, Massachusetts Hong Kong
Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong Moldova
ICS ARENSIA Exploratory Medicine SRL, Chisinau New Zealand
New Zealand Clinical Research, Auckland Last updated September 2025